Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pauline Verdijk"'
Autor:
Johan L. Van Der Plas, Pauline Verdijk, Emilie M. J. Van Brummelen, Rienk E. Jeeninga, Meta Roestenberg, Jacobus Burggraaf, Ingrid M.C. Kamerling
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1322-1326 (2020)
One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies t
Externí odkaz:
https://doaj.org/article/5b502c9fc390473da186d46f3123535f
Autor:
I. Jolanda M. de Vries, Wim J. Oyen, Carl G. Figdor, Arend Heerschap, Gosse J. Adema, Cornelius J.A. Punt, Maichel van Riel, W. Joost Lesterhuis, Mandy van de Rakt, Gerty Schreibelt, Pauline Verdijk, Luis J. Cruz, Fernando Bonetto, Mangala Srinivas, Erik H.J.G. Aarntzen
PDF file - 62K, This table describes patient details, including disease state and prior treatments.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f783933a216adb9f2d894d82427c6d7
https://doi.org/10.1158/1078-0432.22450998
https://doi.org/10.1158/1078-0432.22450998
Autor:
I. Jolanda M. de Vries, Wim J. Oyen, Carl G. Figdor, Arend Heerschap, Gosse J. Adema, Cornelius J.A. Punt, Maichel van Riel, W. Joost Lesterhuis, Mandy van de Rakt, Gerty Schreibelt, Pauline Verdijk, Luis J. Cruz, Fernando Bonetto, Mangala Srinivas, Erik H.J.G. Aarntzen
Purpose: Anticancer dendritic cell (DC) vaccines require the DCs to relocate to lymph nodes (LN) to trigger immune responses. However, these migration rates are typically very poor. Improving the targeting of ex vivo generated DCs to LNs might increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23681b5ba4639c1a80ea210b0fe25f11
https://doi.org/10.1158/1078-0432.c.6522075.v1
https://doi.org/10.1158/1078-0432.c.6522075.v1
Autor:
Pauline Verdijk, Meta Roestenberg, Ingrid M C Kamerling, Emilie M. J. van Brummelen, Johan L. van der Plas, Rienk E. Jeeninga, Jacobus Burggraaf
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies t
Autor:
Otto J de Boer, Elly van Riet, Renée A J van Boxtel, Pauline Verdijk, Tjeert T Mensinga, Willem Luytjes
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:983-990
BACKGROUND: Influenza vaccine production capacity is still insufficient to meet global demand in case of a pandemic. To expand worldwide influenza vaccine production capacity, a solid and transferable egg-based influenza vaccine production process wa
Autor:
Wilfried A.M. Bakker, Roland W. Sutter, Hiromasa Okayasu, M. Steven Oberste, William C. Weldon, Pauline Verdijk, Monique G.C.T. van Oijen, Nynke Y. Rots
Publikováno v:
Vaccine. 32:4938-4944
Background An inactivated poliovirus vaccine (IPV) based on attenuated poliovirus strains (Sabin-1, -2 and -3) was developed for technology transfer to manufacturers in low- and middle-income countries in the context of the global polio eradication i
Autor:
Leo G. Visser, Claire J. P. Boog, Alienke J. Wijmenga-Monsuur, Nynke Y. Rots, Patrick Koedam, Pauline Verdijk, Darius Soonawala
Publikováno v:
Vaccine, 31(36), 3688-3694
For global eradication of poliomyelitis, inactivated poliovirus vaccine (IPV) needs to become available in all countries. Using fractional-doses (reduced-doses) may impact affordability and optimize the utilization of the production capacity. Intrade
Autor:
I. Jolanda M. de Vries, Gerty Schreibelt, J. Han van Krieken, Cornelis J. A. Punt, Willeke A. M. Blokx, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Otto C. Boerman, Pauline Verdijk, Johannes J. Bonenkamp, Carl G. Figdor, Annemiek J. de Boer, Marie-Jeanne P. Gerritsen, Gosse J. Adema, Marieke Kerkhoff, Wim J.G. Oyen, Femke Eijckeler, Danita H. Schuurhuis, Erik H.J.G. Aarntzen
Publikováno v:
Cancer research, 69(7), 2927-2934. American Association for Cancer Research Inc.
Cancer Research, 69, 2927-34
Cancer Research, 69, 7, pp. 2927-34
Cancer Research, 69, 2927-34
Cancer Research, 69, 7, pp. 2927-34
Contains fulltext : 80296.pdf (Publisher’s version ) (Open Access) Electroporation of dendritic cells (DC) with mRNA encoding tumor-associated antigens (TAA) for cancer immunotherapy has been proved efficient and clinically safe. It obviates prior
Autor:
J. Han J.M. vanKrieken, A. C. Inge Boullart, Cornelis J. A. Punt, Willeke A. M. Blokx, Johannes J. Bonenkamp, Ellemieke Kok, Carl G. Figdor, W. Joost Lesterhuis, I. Jolanda M. de Vries, Wim J.G. Oyen, Otto C. Boerman, Gosse J. Adema, Michelle M. van Rossum, Pauline Verdijk, Erik H.J.G. Aarntzen, Joannes F M Jacobs, Femke Eijckeler, Irma Joosten, S. P. Strijk
Publikováno v:
Clinical Cancer Research, 15, 7, pp. 2531-40
Clinical cancer research, 15(7), 2531-2540. American Association for Cancer Research Inc.
Clinical Cancer Research, 15, 2531-40
Clinical cancer research, 15(7), 2531-2540. American Association for Cancer Research Inc.
Clinical Cancer Research, 15, 2531-40
Purpose: The success of immunotherapy with dendritic cells (DC) to treat cancer is dependent on effective migration to the lymph nodes and subsequent activation of antigen-specific T cells. In this study, we investigated the fate of DC after intrader
Publikováno v:
Human vaccinesimmunotherapeutics. 10(9)
Introduction of Haemophilus influenzae type b (Hib) vaccine in low- and middle-income countries has been limited by cost and availability of Hib conjugate vaccines for a long time. It was previously recognized by the Institute for Translational Vacci